Table 3.
Individual imaging findings by pain pattern in chronic pancreatitis patients in the NAPS2-CV study
| Variable | All Patients (518) | Pain pattern | P-Value | |||||
|---|---|---|---|---|---|---|---|---|
| No Pain (81) | A (67) | B (23) | C (98) | D (229) | E (19) | |||
| Calcification | 276 (53.3) | 49 (60.5) | 37 (55.2) | 12 (50) | 58 (59.2) | 107 (46.7) | 13 (68.4) | 0.11 |
| Calcification* | 286 (55.2) | 51 (63) | 41 (61.2) | 12 (50) | 59 (60.2) | 109 (47.6) | 14 (73.7) | 0.0324 |
| Atrophy | 281 (54.3) | 50 (61.7) | 37 (55.2) | 16 (66.7) | 48 (49) | 121 (52.8) | 9 (47.4) | 0.41 |
| Atrophy* | 297 (57.3) | 53 (65.4) | 38 (56.7) | 18 (75) | 50 (51) | 128 (55.9) | 10 (52.6) | 0.21 |
| PD Dilatation | 317 (61.2) | 50 (61.7) | 44 (65.7) | 14 (58.3) | 64 (65.3) | 135 (59) | 10 (52.6) | 0.79 |
| PD Dilatation* | 350 (67.6) | 52 (64.2) | 49 (73.1) | 15 (62.5) | 70 (71.4) | 151 (65.9) | 13 (68.4) | 0.76 |
| PD Stricture/Obstruction | 103 (19.9) | 10 (12.4) | 16 (23.9) | 2 (8.3) | 26 (26.5) | 46 (20.1) | 3 (15.8) | 0.13 |
| PD Stricture/Obstruction* | 142 (27.4) | 17 (21) | 22 (32.8) | 3 (12.5) | 30 (30.6) | 63 (27.5) | 7 (36.8) | 0.24 |
| Pseudocyst | 137 (26.5) | 16 (19.8) | 24 (35.8) | 5 (20.8) | 18 (18.4) | 70 (30.6) | 4 (21.1) | 0.0544 |
| Pseudocyst* | 167 (32.2) | 19 (23.5) | 28 (41.8) | 5 (20.8) | 24 (24.5) | 86 (37.6) | 5 (26.3) | 0.0229 |
| PD Irregularity | 266 (51.4) | 34 (42) | 38 (56.7) | 14 (58.3) | 57 (58.2) | 115 (50.2) | 8 (42.1) | 0.25 |
| Inflammation | 176 (34) | 23 (28.4) | 19 (28.4) | 4 (16.7) | 37 (37.8) | 82 (35.8) | 11 (57.9) | 0.0497 |
| Pancreatic Mass | 30 (5.8) | 6 (7.4) | 3 (4.5) | 1 (4.2) | 9 (9.2) | 9 (3.9) | 2 (10.5) | 0.31 |
| Abnormal Side Branches | 213 (41.1) | 27 (33.3) | 35 (52.2) | 11 (45.8) | 36 (36.7) | 97 (42.4) | 7 (36.8) | 0.24 |
| CBD Stricture | 61 (11.8) | 9 (11.1) | 10 (14.9) | 3 (12.5) | 19 (19.4) | 19 (8.3) | 1 (5.3) | 0.0911 |
| CBD Dilatation | 92 (17.8) | 16 (19.8) | 17 (25.4) | 4 (16.7) | 20 (20.4) | 32 (14) | 3 (15.8) | 0.31 |
| Changes of Cirrhosis and/or Portal Hypertension | 64 (12.4) | 7 (8.6) | 9 (13.4) | 2 (8.3) | 11 (11.2) | 30 (13.1) | 5 (26.3) | 0.40 |
Findings are those reported on the most recent imaging studies, except for those marked with an (*) which reflects findings reported on imaging studies performed anytime